Cargando…
Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer
Response Evaluation Criteria in Solid Tumors (RECIST) is used to assess the objective response of solid tumors to treatment. However, it remains unclear to what extent the response rate assessed by RECIST reflects a reduction of tumor size in multiple organs in patients with unresectable advanced or...
Autores principales: | Kawagoe, Shiho, Nakano, Masahiro, Uchino, Keita, Arimizu, Kohei, Kajitani, Tatsuhiro, Shimokawa, Hozumi, Kusumoto, Tetsuya, Ikejiri, Koji, Baba, Eishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667888/ https://www.ncbi.nlm.nih.gov/pubmed/31396385 http://dx.doi.org/10.3892/mco.2019.1894 |
Ejemplares similares
-
Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma
por: Ohmura, Hirofumi, et al.
Publicado: (2017) -
Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: a case report
por: Sagara, Kosuke, et al.
Publicado: (2014) -
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan
por: Tsuchihashi, Kenji, et al.
Publicado: (2023) -
Improvement of quality of life and survival using self-expandable metal stent placement for severe malignant stenosis of the gastric body: a case report
por: Kumagai, Hozumi, et al.
Publicado: (2012) -
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
por: Shirakawa, Tsuyoshi, et al.
Publicado: (2023)